共 31 条
Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia
被引:60
作者:
Chen, Ru
[1
]
Pan, Sheng
[2
]
Duan, Xiaobo
[3
]
Nelson, Brad H.
[3
]
Sahota, Rob A.
[3
]
de Rham, Sarah
[3
]
Kozarek, Richard A.
[4
]
McIntosh, Martin
[5
]
Brentnall, Teresa A.
[1
]
机构:
[1] Univ Washington, Dept Med, GI Div, Seattle, WA 98195 USA
[2] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[3] BC Canc Agcy, Victoria, BC V8R 6V5, Canada
[4] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[5] Fred Hutchinson Canc Res Ctr, Div Publ Hlth, Seattle, WA 98109 USA
来源:
关键词:
DUCTAL ADENOCARCINOMA;
QUANTITATIVE-ANALYSIS;
MOLECULAR MARKERS;
STATISTICAL-MODEL;
MESSENGER-RNA;
CANCER;
PROTEIN;
AGR2;
EXPRESSION;
PROTEOMICS;
D O I:
10.1186/1476-4598-9-149
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
070307 [化学生物学];
071010 [生物化学与分子生物学];
摘要:
Background: Pancreatic intraepithelial neoplasias (PanINs) are precursors of malignant pancreatic cancer, an ideal stage for early cancer detection. We applied quantitative proteomics to identify aberrantly elevated proteins in pancreatic juice samples derived from patients with PanIN3. Results: Twenty proteins were found elevated in all three PanIN juices by at least two-fold. Among these proteins, anterior gradient-2 (AGR2) was found to be 2-10 fold elevated in PanIN3 juice samples analyzed by quantitative proteomics. An ELISA assay was developed to evaluate AGR2 levels in 51 pancreatic juice samples and 23 serum samples from patients with pancreatic cancer, pre-malignant lesions (including PanIN3, PanIN2, Intraductal Papillary Mucinous Neoplasms (IPMNs)) and benign disease controls (including chronic pancreatitis). AGR2 levels in the pancreatic juice samples were found significantly elevated in patients with pre-malignant conditions (PanINs and IPMNs) as well as pancreatic cancer compared to control samples (p <= 0.03). By ROC analysis, the AGR2 ELISA achieved 67% sensitivity at 90% specificity in predicting PanIN3 juice samples from the benign disease controls. Conclusions: These results suggest that elevation of AGR2 levels in pancreatic juice occurs in early pancreatic cancer progression and could be further investigated as a potential candidate juice biomarker for early detection of pancreatic cancer.
引用
收藏
页数:12
相关论文

